A detailed history of Deutsche Bank Ag\ transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 238,390 shares of PYXS stock, worth $402,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares
238,390
Previous 238,390 -0.0%
Holding current value
$402,879
Previous $789,000 10.77%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.06 - $5.58 $224,573 - $409,516
73,390 Added 44.48%
238,390 $789,000
Q1 2024

May 15, 2024

BUY
$2.03 - $6.59 $81,199 - $263,600
40,000 Added 32.0%
165,000 $702,000
Q2 2023

Aug 14, 2023

BUY
$2.46 - $4.07 $246,000 - $407,000
100,000 Added 400.0%
125,000 $320,000
Q2 2022

Aug 11, 2022

SELL
$2.02 - $4.53 $11,681 - $26,196
-5,783 Reduced 18.79%
25,000 $60,000
Q1 2022

May 13, 2022

SELL
$4.04 - $11.43 $2,739 - $7,749
-678 Reduced 2.16%
30,783 $124,000
Q4 2021

Feb 11, 2022

BUY
$8.39 - $13.64 $263,957 - $429,128
31,461 New
31,461 $345,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.